Dongsung Pharmaceutical Co., Ltd.(KR:002210)
₩1,101.00-10.00 (-0.90%)
KR:002210
Dongsung Pharmaceutical Co., Ltd. financials statements
₩1,101.00
At close:-10.00 (-0.90%)
Want to see KR:002210 full AI Analyst Report?
Dongsung Pharmaceutical Co., Ltd. (002210) Income Statement
Dongsung Pharmaceutical Co., Ltd. Income Statement
Last quarter (Q2 2026), Dongsung Pharmaceutical Co., Ltd.'s total revenue was ₩22.08B, an increase of 10.64% from the same quarter last year. In Q2, Dongsung Pharmaceutical Co., Ltd.'s net income was ₩-5.89B. See Dongsung Pharmaceutical Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| ₩ 87.17B | ₩ 88.45B | ₩ 88.59B | ₩ 93.33B | ₩ 84.41B | |
| ₩ 36.36B | ₩ 38.88B | ₩ 41.37B | ₩ 42.06B | ₩ 33.54B | |
| ₩ 59.23B | ₩ 45.48B | ₩ 40.77B | ₩ 45.15B | ₩ 38.84B | |
| Depreciation and Amortization | ₩ 2.14B | ₩ 2.04B | ₩ 2.05B | ₩ 2.12B | ₩ 2.22B |
| ₩ -20.73B | ₩ -1.88B | ₩ 3.42B | ₩ 1.58B | ₩ -1.44B | |
| ₩ -22.87B | ₩ -6.59B | ₩ 596.40M | ₩ -2.04B | ₩ -5.30B | |
| ₩ -5.82B | ₩ -1.06B | ₩ -1.46B | ₩ 191.20M | ₩ 919.71M | |
| ₩ -28.69B | ₩ -7.66B | ₩ -865.89M | ₩ -1.85B | ₩ -4.38B | |
| ₩ -25.74B | ₩ -7.25B | ₩ -2.07B | ₩ -2.12B | ₩ -4.31B | |
| Per Share Metrics | |||||
| Basic EPS | ₩ -1125.56 | ₩ -317.64 | ₩ -90.70 | ₩ -92.23 | ₩ -184.52 |
| Diluted EPS | ₩ -1125.56 | ₩ -317.20 | ₩ -86.74 | ₩ -87.74 | ₩ -184.29 |
| Weighted Average Shares Outstanding | 22.87M | 22.87M | 22.87M | 23.00M | 23.37M |
| Weighted Average Shares Outstanding (Diluted) | 22.87M | 22.87M | 23.91M | 24.18M | 23.40M |
Currency in KRW
